Ads
related to: drugs, prostate cancer- nmCRPC Treatment Option
31% Risk of Death Decrease
Visit The Patient Site.
- Clinical Information
Read About A Double-Blind, Placebo-
Controlled, Randomized Study.
- mHSPC Treatment Option
32% Risk of Death Decrease
Visit The Patient Site.
- Dosing & Administration
View Recommended Dosage & Learn
About Drug Interactions Here.
- Patient Profiles
Explore Patient Profiles To Assess
A Treatment Option.
- Representatives Available
Stay Informed And Get More Info
From A Team Of Representatives.
- nmCRPC Treatment Option
akumin.com has been visited by 10K+ users in the past month
Search results
Prostate cancer: Supplement, keto diet may boost immunotherapy
Medical News Today· 1 day agoAbout 13% of cisgender men around the world will receive a prostate cancer diagnosis in their...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
WTNH-TV New Haven· 2 hours agoJohnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study...
Angle to Develop Prostate Cancer Liquid Biopsy Assay for AstraZeneca
GenomeWeb News· 4 hours agoAngle announced on Friday that it has signed a supplier agreement with AstraZeneca to develop an androgen receptor (AR) assay to assess prostate cancer ...
Why selling to Novartis made sense for Mariana
BioPharma Dive via Yahoo Finance· 6 hours agoNovartis’ success with Pluvicto in prostate cancer has motivated others, Mariana among them, to follow into the field. “We began thinking in mid-2020...
Swing Against Cancer 2024 breaks records, raises $220,000 for research
The Desert Sun via Yahoo News· 10 hours agoAfter presenting an engaging audience participation exercise about statistics in cancer research and...
New Trials in Prostate Cancer: Could Your Patient Benefit?
Medscape· 5 days agoPerhaps one of your patients could benefit from a clinical trial that has recently opened in ...
Men on hair-loss drug warned of sexual and psychiatric side effects
The Telegraph via Yahoo News· 4 days agoIt has also ordered suppliers of finasteride to now include a patient alert card in packs of the ...
Angle PLC Announces New Commercial Agreement with Large Pharma
Digital Journal· 12 hours agoANGLE commissioned to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies GUILDFORD, SURREY / ACCESSWIRE / May ...
Trelstar dosage: Form, strengths, how to use, and more
Medical News Today· 2 days agoTrelstar (triptorelin pamoate) is a brand-name drug that’s prescribed for advanced prostate cancer...
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032
WTNH-TV New Haven· 2 hours agoAccording to a "highly troubling" new study, the rising number of cancer cases in young people is...
Ads
related to: drugs, prostate cancerakumin.com has been visited by 10K+ users in the past month
